Saturday, 13 September, 2025г.
russian english deutsch french spanish portuguese czech greek georgian chinese japanese korean indonesian turkish thai uzbek

пример: покупка автомобиля в Запорожье

 

Daniel Petrylak, MD shares his thoughts on the CARD study presented at ASCO GU 2020

Daniel Petrylak, MD shares his thoughts on the CARD study presented at ASCO GU 2020У вашего броузера проблема в совместимости с HTML5
Dr. Petrylak, Professor of Medicine and Urology, Yale Cancer Center, on the CARD study investigating the role of cabazitaxel in metastatic castration-resistant prostate cancer patients
Опубликовано: 15-02-2020
Похожие видео
Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 2020

Daniel Catenacci, MD, elaborates on the outcomes of the JAVELIN 100 study presented at ASCO GI 202002:43

David H Ilson, MD, elaborates on updated data from the BEACON study presented at ASCO GI 2020

David H Ilson, MD, elaborates on updated data from the BEACON study presented at ASCO GI 202002:23

Expert comment: The CARD, TITAN, and STOMP trials | Robert Dreicer

Expert comment: The CARD, TITAN, and STOMP trials | Robert Dreicer03:08

Dr. David Samadi - Prostate Cancer Surgery vs. Prostate Cancer Radiation

Dr. David Samadi - Prostate Cancer Surgery vs. Prostate Cancer Radiation00:54

Мой аккаунт

Вход / Log In